DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY)

Historical Holders from Q1 2014 to Q3 2025

Symbol
RDY on NYSE
CUSIP
256135203
Type / Class
Equity / American depositary shares, each representing one equity share
Shares outstanding
835M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
107M
Holdings value
$1.49B
% of all portfolios
0.004%
Grand Portfolio weight change
0%
Number of holders
220
Number of buys
106
Number of sells
-112
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Prasad G V 13.58% $1.61B 113M K. Satish Reddy Sep 17, 2025

Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 107M $1.49B -$18.1M $13.98 220
2025 Q2 107M $1.61B -$2.44M $15.03 237
2025 Q1 110M $1.44B -$148M $13.19 238
2024 Q4 118M $1.87B +$1.38B $15.79 244
2024 Q3 22.3M $1.77B -$33.4M $79.45 218
2024 Q2 24.1M $1.84B +$26.3M $76.19 219
2024 Q1 23.6M $1.73B +$4.04M $73.35 228
2023 Q4 99.6K $6.93M +$184K $69.58 2
2023 Q3 19.7M $1.31B +$168M $66.87 205
2023 Q2 17.8M $1.13B +$125M $63.11 186
2023 Q1 15.9M $903M +$137M $56.93 184
2022 Q4 13.4M $693M +$9.91M $51.75 157
2022 Q3 13.3M $696M +$47.2M $52.34 145
2022 Q2 12.4M $685M -$25.4M $55.39 146
2022 Q1 16.6M $924M +$5.95M $55.73 144
2021 Q4 16.5M $1.07B -$46.3M $65.41 140
2021 Q3 17M $1.11B -$95.4M $65.14 144
2021 Q2 15M $1.11B +$18.4M $73.51 156
2021 Q1 18.3M $1.13B -$12.1M $61.39 159
2020 Q4 15.6M $1.11B -$141M $71.29 168
2020 Q3 17.2M $1.19B -$19.5M $69.56 179
2020 Q2 18M $952M +$24.4M $53.01 166
2020 Q1 21.3M $860M -$4.45M $40.33 141
2019 Q4 21.4M $867M +$19.3M $40.58 140
2019 Q3 21M $795M -$26.2M $37.89 146
2019 Q2 21.6M $811M +$17.9M $37.47 144
2019 Q1 21.1M $855M +$29.8M $40.50 139
2018 Q4 20.4M $769M +$59.3M $37.70 139
2018 Q3 18.9M $650M -$42.4M $34.60 120
2018 Q2 20.3M $654M -$56.1M $32.20 129
2018 Q1 21.8M $711M +$199K $32.69 118
2017 Q4 21.8M $817M -$23.7M $37.56 115
2017 Q3 22.7M $811M -$47.7M $35.68 116
2017 Q2 25.2M $1.06B +$7.82M $42.14 124
2017 Q1 24.9M $1B -$47.4M $40.15 129
2016 Q4 27.2M $1.23B +$10.9M $45.28 157
2016 Q3 26.6M $1.23B -$10.4M $46.42 151
2016 Q2 26.8M $1.39B -$11.5M $51.23 152
2016 Q1 26.6M $1.21B -$77.7M $45.19 153
2015 Q4 28.1M $1.31B -$1.11M $46.29 165
2015 Q3 27.9M $1.78B +$178M $63.91 198
2015 Q2 24.8M $1.37B +$39.8M $55.32 182
2015 Q1 24.5M $1.39B -$54.8M $57.10 168
2014 Q4 25.5M $1.28B +$45.9M $50.45 163
2014 Q3 24.2M $1.27B -$18.3M $52.55 156
2014 Q2 25.5M $1.1B +$39.8M $43.15 167
2014 Q1 24.3M $1.07B +$90.3M $43.90 165